The Technical Advisory Group of WHO will conduct a EUL risk-benefit assessment meeting for the global use of Bharat Biotech's COVID jab, Covaxin, today.
The Central Drugs Standard Control Organisation (CDSCO) on Wednesday approved the extension of the shelf life of Bharat Biotech's Covaxin up to 12 months.
The WHO's decision on including Covaxin in its Emergency Use Listing was delayed again after the UN health agency sought clarifications from Bharat Biotech.
In a big announcement, the World Health Organization declared that it will decide on including Covaxin in its Emergency Use Listing in the month of October.
WHO s emergency use approval for Covaxin delayed; more data sought from Bharat Biotech republicworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from republicworld.com Daily Mail and Mail on Sunday newspapers.